Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Merav Leiba

Showing results (21-30 of 68) with videos related to

Pageof 7
Sort By:
Cells|March 29, 2023
Effect of HPSE and HPSE2 SNPs on the Risk of Developing Primary Paraskeletal Multiple MyelomaOlga Ostrovsky, Katia Beider, Hila Magen, et al.
Clinical Laboratory|September 20, 2022
Effective Neutralization of Daratumumab Effects on Pre-Transfusion Testing: a Method ModificationAnna Feldman, Adrian M Duek, Mathilda Mandel-Benado, et al.
British Journal of Haematology|May 28, 2014
Bortezomib-cyclophosphamide-dexamethasone (VCD) versus bortezomib-thalidomide-dexamethasone (VTD) -based regimens as induction therapies in newly diagnosed transplant eligible patients with multiple myeloma: a meta-analysisMerav Leiba, Meirav Kedmi, Adrian Duek, et al.
Cancer|February 23, 2016
Adolescent weight and height are predictors of specific non-Hodgkin lymphoma subtypes among a cohort of 2,352,988 individuals aged 16 to 19 yearsMerav Leiba, Adi Leiba, Lital Keinan-Boker, et al.
Acta Haematologica|November 11, 2006
Characterization of HPSE gene single nucleotide polymorphisms in Jewish populations of IsraelOlga Ostrovsky, Michael Korostishevsky, Iris Levite, et al.
Clinical and Experimental Nephrology|February 9, 2019
Kidney disease and plasma cell dyscrasias: ambiguous cases solved by serum free light chain dimerization analysisOlga Kukuy, Batia Kaplan, Sizilia Golderman, et al.
American Journal of Cancer Research|December 15, 2025
STK405759 targets microtubules, modulates STAT1, and enhances ruxolitinib efficacy in myeloproliferative neoplasmsGabriela Rozic, Yaara Makaros, Irit Shapira-Netanelov, et al.
American Journal of Hematology|May 29, 2014
Immunoglobulin-free light chain monomer-dimer patterns help to distinguish malignant from premalignant monoclonal gammopathies: a pilot studyBatia Kaplan, Sizilia Golderman, Boris Aizenbud, et al.
Leukemia & Lymphoma|August 27, 2016
Risk of Hodgkin lymphoma according to immigration status and origin: a migrant cohort study of 2.3 million Jewish IsraelisHagai Levine, Merav Leiba, Yael Bar Zeev, et al.
Leukemia & Lymphoma|December 24, 2013
Israeli-born offspring of Jewish immigrants of Middle Eastern origin have a lower incidence of multiple myeloma than those of European origin: a cohort study of 746 200 Israeli men followed from late adolescenceMerav Leiba, Arnon Afek, Estela Derazne, et al.
Pageof 7

Showing results (21-30 of 68) with videos related to

Sort By:
Pageof 7
Cells|March 29, 2023
Effect of HPSE and HPSE2 SNPs on the Risk of Developing Primary Paraskeletal Multiple MyelomaOlga Ostrovsky, Katia Beider, Hila Magen, et al.
Clinical Laboratory|September 20, 2022
Effective Neutralization of Daratumumab Effects on Pre-Transfusion Testing: a Method ModificationAnna Feldman, Adrian M Duek, Mathilda Mandel-Benado, et al.
British Journal of Haematology|May 28, 2014
Bortezomib-cyclophosphamide-dexamethasone (VCD) versus bortezomib-thalidomide-dexamethasone (VTD) -based regimens as induction therapies in newly diagnosed transplant eligible patients with multiple myeloma: a meta-analysisMerav Leiba, Meirav Kedmi, Adrian Duek, et al.
Cancer|February 23, 2016
Adolescent weight and height are predictors of specific non-Hodgkin lymphoma subtypes among a cohort of 2,352,988 individuals aged 16 to 19 yearsMerav Leiba, Adi Leiba, Lital Keinan-Boker, et al.
Acta Haematologica|November 11, 2006
Characterization of HPSE gene single nucleotide polymorphisms in Jewish populations of IsraelOlga Ostrovsky, Michael Korostishevsky, Iris Levite, et al.
Clinical and Experimental Nephrology|February 9, 2019
Kidney disease and plasma cell dyscrasias: ambiguous cases solved by serum free light chain dimerization analysisOlga Kukuy, Batia Kaplan, Sizilia Golderman, et al.
American Journal of Cancer Research|December 15, 2025
STK405759 targets microtubules, modulates STAT1, and enhances ruxolitinib efficacy in myeloproliferative neoplasmsGabriela Rozic, Yaara Makaros, Irit Shapira-Netanelov, et al.
American Journal of Hematology|May 29, 2014
Immunoglobulin-free light chain monomer-dimer patterns help to distinguish malignant from premalignant monoclonal gammopathies: a pilot studyBatia Kaplan, Sizilia Golderman, Boris Aizenbud, et al.
Leukemia & Lymphoma|August 27, 2016
Risk of Hodgkin lymphoma according to immigration status and origin: a migrant cohort study of 2.3 million Jewish IsraelisHagai Levine, Merav Leiba, Yael Bar Zeev, et al.
Leukemia & Lymphoma|December 24, 2013
Israeli-born offspring of Jewish immigrants of Middle Eastern origin have a lower incidence of multiple myeloma than those of European origin: a cohort study of 746 200 Israeli men followed from late adolescenceMerav Leiba, Arnon Afek, Estela Derazne, et al.
Pageof 7